The goal of this application is to identify predictive markers for outcomes of natural infection and/or vaccination with influenza, markers that are perhaps applicable to other infectious agents defined in the RFA. We have assembled a multi-disciplinary team composed of relevant infectious disease experts, clinical experts with access to appropriate patient samples, and experts in assay development, qualification, and validation. We will take advantage of a newly discovered predictive signature from the Khatri lab; unique clinical cohorts developed by the Dekker and Davis groups; Stanford?s Human Immune Monitoring Center (HIMC) for analysis of blood samples using Fluidigm, FACS and CyTOF; and expertise in multiplexed assay development by the Wang and Utz labs. Although beyond the scope of our application, the biomarker signature and the assays developed herein can be used to study other infectious agents and vaccine strategies that will be funded under this RFA mechanism. Our three specific aims will focus on the validation, application and translation of this signature.
Specific Aim 1 is to validate a panel of biomarkers for their ability to predict response to influenza vaccination and recovery from wild-type influenza virus infection.
Specific Aim 2 will characterize biological pathways identified in Aim 1 using well-established and previously described patient cohorts, and to compare the existing biomarker datasets that are available. Finally, Specific Aim 3 will develop a rapid, multiplexed assay for measuring transcripts using Giant MagnetoResistive (GMR) Sensors, with a long term goal to build a sensor capable of measuring multiple transcripts within minutes at point-of-assay. Our studies will enhance our understanding of the important biological processes involved in response to influenza and other pathogens, and will provide a clinically accessible immune metric for rapid or even real-time evaluation of patients and vaccines.

Public Health Relevance

We will validate using PCR and microfluidics an 11 gene transcript profile, recently discovered using a ?Big Data? approach, that predicts influenza vaccine responsiveness. We will explore the underlying biology of the pathways we have discovered and will translate the assay to a sensitive and rapid new platform that uses Giant MagnetoResistive Sensors.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI125197-04
Application #
9753117
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Gordon, Jennifer L
Project Start
2016-08-10
Project End
2021-07-31
Budget Start
2019-08-01
Budget End
2020-07-31
Support Year
4
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Gee, Marvin H; Han, Arnold; Lofgren, Shane M et al. (2018) Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell 172:549-563.e16
Vallania, Francesco; Tam, Andrew; Lofgren, Shane et al. (2018) Leveraging heterogeneity across multiple datasets increases cell-mixture deconvolution accuracy and reduces biological and technical biases. Nat Commun 9:4735
Bongen, Erika; Vallania, Francesco; Utz, Paul J et al. (2018) KLRD1-expressing natural killer cells predict influenza susceptibility. Genome Med 10:45
Cheung, Peggie; Vallania, Francesco; Warsinske, Hayley C et al. (2018) Single-Cell Chromatin Modification Profiling Reveals Increased Epigenetic Variations with Aging. Cell 173:1385-1397.e14
Sweeney, Timothy E; Thomas, Neal J; Howrylak, Judie A et al. (2018) Multicohort Analysis of Whole-Blood Gene Expression Data Does Not Form a Robust Diagnostic for Acute Respiratory Distress Syndrome. Crit Care Med 46:244-251
Degn, Søren E; van der Poel, Cees E; Firl, Daniel J et al. (2017) Clonal Evolution of Autoreactive Germinal Centers. Cell 170:913-926.e19
Perkins, Tiffany; Rosenberg, Jacob M; Le Coz, Carole et al. (2017) Smith-Magenis Syndrome Patients Often Display Antibody Deficiency but Not Other Immune Pathologies. J Allergy Clin Immunol Pract 5:1344-1350.e3
Lofgren, Shane; Hinchcliff, Monique; Carns, Mary et al. (2016) Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severity. JCI Insight 1:e89073